• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在具有富集作用的适应性临床试验中进行疗效测试。

Testing for efficacy in adaptive clinical trials with enrichment.

作者信息

Wu Samuel S, Tu Yi-Hsuan, He Ying

机构信息

Department of Biostatistics, University of Florida, Gainesville, FL 32610, U.S.A.

出版信息

Stat Med. 2014 Jul 20;33(16):2736-45. doi: 10.1002/sim.6127. Epub 2014 Feb 27.

DOI:10.1002/sim.6127
PMID:24577792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4362733/
Abstract

Adaptive design of clinical trials has attracted considerable interest because of its potential of reducing costs and saving time in the clinical development process. In this paper, we consider the problem of assessing the effectiveness of a test treatment over a control by a two-arm randomized clinical trial in a potentially heterogenous patient population. In particular, we study enrichment designs that use accumulating data from a clinical trial to adaptively determine patient subpopulation in which the treatment effect is eventually assessed. A hypothesis testing procedure and a lower confidence limit are presented for the treatment effect in the selected patient subgroups. The performances of the new methods are compared with existing approaches through a simulation study.

摘要

由于自适应设计在临床试验开发过程中具有降低成本和节省时间的潜力,因此备受关注。在本文中,我们考虑在一个可能存在异质性的患者群体中,通过双臂随机临床试验评估试验治疗相对于对照治疗有效性的问题。具体而言,我们研究富集设计,该设计利用来自临床试验的累积数据来自适应地确定最终评估治疗效果的患者亚组。针对所选患者亚组中的治疗效果,提出了一种假设检验程序和一个下限置信区间。通过模拟研究将新方法的性能与现有方法进行了比较。

相似文献

1
Testing for efficacy in adaptive clinical trials with enrichment.在具有富集作用的适应性临床试验中进行疗效测试。
Stat Med. 2014 Jul 20;33(16):2736-45. doi: 10.1002/sim.6127. Epub 2014 Feb 27.
2
Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials.临床试验适应性富集设计中数据驱动亚组的治疗评估
Stat Med. 2018 Jan 15;37(1):1-11. doi: 10.1002/sim.7497. Epub 2017 Sep 26.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial.用于响应自适应随机设计的瓮模型:基于非自适应随机试验的模拟研究
J Biopharm Stat. 2018;28(6):1203-1215. doi: 10.1080/10543406.2018.1452024. Epub 2018 Mar 22.
5
On Enrichment Strategies for Biomarker Stratified Clinical Trials.关于生物标志物分层临床试验的富集策略
J Biopharm Stat. 2018;28(2):292-308. doi: 10.1080/10543406.2017.1379532. Epub 2017 Oct 30.
6
Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints.适用于带有时间事件终点的适应性富集设计的患者招募策略。
BMC Med Res Methodol. 2019 Jul 22;19(1):159. doi: 10.1186/s12874-019-0800-2.
7
Using Bayesian modeling in frequentist adaptive enrichment designs.在频率主义者自适应富集设计中使用贝叶斯建模。
Biostatistics. 2018 Jan 1;19(1):27-41. doi: 10.1093/biostatistics/kxw054.
8
Familywise error control in multi-armed response-adaptive two-stage designs.多臂响应自适应两阶段设计中的家族性错误控制
J Biopharm Stat. 2011 Jul;21(4):818-30. doi: 10.1080/10543406.2011.551337.
9
Point estimation following two-stage adaptive threshold enrichment clinical trials.两阶段自适应阈值富集临床试验后的点估计。
Stat Med. 2018 Sep 30;37(22):3179-3196. doi: 10.1002/sim.7831. Epub 2018 May 31.
10
Enrichment Bayesian design for randomized clinical trials using categorical biomarkers and a binary outcome.基于分类生物标志物和二分类结局的随机临床试验的富集贝叶斯设计。
BMC Med Res Methodol. 2022 Feb 27;22(1):54. doi: 10.1186/s12874-022-01513-z.

引用本文的文献

1
Confidence Intervals for Adaptive Trial Designs I: A Methodological Review.适应性试验设计的置信区间I:方法学综述
Stat Med. 2025 Aug;44(18-19):e70174. doi: 10.1002/sim.70174.
2
Two-stage adaptive enrichment design for testing an active factor.两阶段自适应富集设计用于检验活性因子。
J Biopharm Stat. 2020;30(1):18-30. doi: 10.1080/10543406.2019.1609015. Epub 2019 May 28.
3
Successful aging: Advancing the science of physical independence in older adults.成功老龄化:推进老年人身体独立的科学研究。
Ageing Res Rev. 2015 Nov;24(Pt B):304-27. doi: 10.1016/j.arr.2015.09.005. Epub 2015 Oct 14.

本文引用的文献

1
Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment.优化随机试验设计以区分哪些亚群从治疗中获益。
Biometrika. 2011 Dec;98(4):845-860. doi: 10.1093/biomet/asr055.
2
Interval estimation in two-stage, drop-the-losers clinical trials with flexible treatment selection.两阶段、有剔除失败者的临床试验中灵活治疗选择的区间估计。
Stat Med. 2011 Oct 15;30(23):2804-14. doi: 10.1002/sim.4308. Epub 2011 Aug 8.
3
Adaptive patient enrichment designs in therapeutic trials.治疗性试验中的适应性患者富集设计。
Biom J. 2009 Apr;51(2):358-74. doi: 10.1002/bimj.200900003.
4
Drug development cost estimates hard to swallow.药物研发成本估计让人难以接受。
CMAJ. 2009 Feb 3;180(3):279-80. doi: 10.1503/cmaj.082040.
5
Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset.基因组亚组随机临床试验中治疗效果评估方法
Pharm Stat. 2007 Jul-Sep;6(3):227-44. doi: 10.1002/pst.300.
6
Use of genomic signatures in therapeutics development in oncology and other diseases.基因组特征在肿瘤学及其他疾病治疗开发中的应用。
Pharmacogenomics J. 2006 May-Jun;6(3):166-73. doi: 10.1038/sj.tpj.6500349.
7
The price of innovation: new estimates of drug development costs.创新的代价:药物研发成本的新估计
J Health Econ. 2003 Mar;22(2):151-85. doi: 10.1016/S0167-6296(02)00126-1.
8
Evaluating treatments when a gender by treatment interaction may exist.当可能存在治疗与性别的交互作用时评估治疗方法。
Stat Med. 1997 Feb 28;16(4):455-64. doi: 10.1002/(sici)1097-0258(19970228)16:4<455::aid-sim382>3.0.co;2-y.
9
An aid to data monitoring in long-term clinical trials.长期临床试验中的数据监测辅助工具。
Control Clin Trials. 1982 Dec;3(4):311-23. doi: 10.1016/0197-2456(82)90022-8.